TOSCANO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 21.570
EU - Europa 18.624
AS - Asia 11.246
SA - Sud America 3.794
Continente sconosciuto - Info sul continente non disponibili 985
AF - Africa 316
OC - Oceania 13
Totale 56.548
Nazione #
US - Stati Uniti d'America 20.974
RU - Federazione Russa 9.658
SG - Singapore 4.723
BR - Brasile 3.212
CN - Cina 3.161
IE - Irlanda 2.406
SE - Svezia 1.614
IT - Italia 1.386
HK - Hong Kong 1.262
DE - Germania 772
VN - Vietnam 616
FR - Francia 561
UA - Ucraina 532
FI - Finlandia 470
PL - Polonia 382
GB - Regno Unito 358
IN - India 340
CA - Canada 252
BD - Bangladesh 204
AR - Argentina 186
MX - Messico 120
TR - Turchia 108
NL - Olanda 107
EC - Ecuador 99
ID - Indonesia 98
ZA - Sudafrica 93
IQ - Iraq 87
JP - Giappone 87
CO - Colombia 80
BE - Belgio 76
AT - Austria 73
PK - Pakistan 70
VE - Venezuela 67
MA - Marocco 56
UZ - Uzbekistan 55
TH - Thailandia 54
PY - Paraguay 51
ES - Italia 50
JM - Giamaica 40
CL - Cile 39
KE - Kenya 34
TN - Tunisia 32
PH - Filippine 31
CR - Costa Rica 29
JO - Giordania 29
MY - Malesia 29
PE - Perù 29
HN - Honduras 28
KZ - Kazakistan 27
LT - Lituania 27
AE - Emirati Arabi Uniti 26
IR - Iran 26
SA - Arabia Saudita 26
CZ - Repubblica Ceca 24
IL - Israele 24
AZ - Azerbaigian 23
CI - Costa d'Avorio 23
EG - Egitto 20
DZ - Algeria 19
NP - Nepal 19
DO - Repubblica Dominicana 18
OM - Oman 18
GT - Guatemala 17
LB - Libano 17
NI - Nicaragua 17
UY - Uruguay 17
TT - Trinidad e Tobago 14
AL - Albania 13
HR - Croazia 13
KR - Corea 13
BO - Bolivia 12
KG - Kirghizistan 11
PR - Porto Rico 11
RS - Serbia 11
SV - El Salvador 11
PA - Panama 10
RO - Romania 10
PT - Portogallo 9
AU - Australia 8
CH - Svizzera 8
PS - Palestinian Territory 8
BG - Bulgaria 7
DK - Danimarca 7
ET - Etiopia 7
GR - Grecia 7
SN - Senegal 7
AM - Armenia 6
BA - Bosnia-Erzegovina 6
EU - Europa 6
LV - Lettonia 6
QA - Qatar 6
AO - Angola 5
BY - Bielorussia 5
BZ - Belize 5
GA - Gabon 5
HU - Ungheria 5
KW - Kuwait 5
LK - Sri Lanka 5
MN - Mongolia 5
SY - Repubblica araba siriana 5
Totale 55.480
Città #
Ashburn 3.158
Moscow 3.037
Dublin 2.404
Singapore 2.267
Dallas 2.184
Chandler 1.488
San Jose 1.291
Hong Kong 1.262
Jacksonville 1.160
Nyköping 1.027
Beijing 973
Council Bluffs 797
The Dalles 559
Los Angeles 453
Princeton 444
Medford 409
Messina 399
Lauterbourg 385
Warsaw 369
Cambridge 334
Des Moines 317
Dearborn 308
New York 301
Ann Arbor 286
São Paulo 242
Buffalo 205
Ho Chi Minh City 200
Santa Clara 178
Munich 175
Wilmington 153
Boardman 149
Tianjin 146
Hanoi 119
Guangzhou 118
Jinan 117
San Mateo 113
Orem 110
Shenyang 108
Phoenix 106
Rome 105
Redondo Beach 104
Atlanta 101
Frankfurt am Main 99
Rio de Janeiro 94
Brooklyn 87
Houston 87
Nanjing 83
Belo Horizonte 79
Tokyo 75
Hyderabad 71
Turku 71
Ningbo 67
Denver 66
Chicago 65
San Francisco 65
Chennai 64
Brasília 63
Helsinki 61
Columbus 60
Milan 60
Nuremberg 57
Zhengzhou 57
Woodbridge 55
Seattle 54
Hebei 52
Montreal 52
Bremen 51
Brussels 51
Curitiba 49
Johannesburg 49
Shenzhen 49
Shanghai 48
Amsterdam 47
Hangzhou 47
Tashkent 47
Catania 44
North Bergen 44
Jakarta 43
Vienna 43
Campinas 42
Falls Church 42
Lancaster 42
Pune 42
Bangkok 41
Taizhou 40
Toronto 40
Guayaquil 39
London 39
Boston 37
Mexico City 37
Dong Ket 36
Porto Alegre 36
Stockholm 35
Mumbai 33
Washington 33
Haikou 32
Manchester 32
Nairobi 32
Quito 32
Salvador 32
Totale 31.191
Nome #
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 744
The relationship between sleep quality and ratio of house size/number of people in chronic migraineurs during Covid-19 lockdown. 314
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 297
Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study 285
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 265
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 262
Clinical and pathological features of focal myositis 257
A CMT1A PATIENT WITH PAINFUL AND DISABLING SYMPTOMS: FAST RECOVERY AFTER IVIG TREATMENT. 257
Ischemic stroke and reperfusion therapies in diabetic patients 257
Five years experience on 3,4-diaminopyridine phosphate in Lambert-Eaton syndrome: Case reports 234
Atypical posterior reversible encephalopathy syndrome with hemispheric brainstem and spinal cord involvement in a patient with acute kidney injury – a case report. 228
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 227
A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies 225
A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT2B) or hereditary sensory neuropathy type I (HSN I) loci 223
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 221
A cytochemical study of apoptosis in metabolic myopathies 217
A life threatening case of β-enolase deficiency 211
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 209
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 207
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 204
A decreased muscle content of HPRG correlates with the reduction of AMP deaminase activity observed in patients affected by myoadenylate deficiencies 203
"Dropped- head" syndrome due to isolated myositis of neck extensor muscles: MRI findings 203
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 203
Dolori muscolari, deficit di forza e/o disturbi sensitivi 203
A novel mutation in KIF5A gene causing hereditary spastic paraplegia with axonal neuropathy. 201
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 200
Community-acquired enterococcal meningitis caused by Enterococcus casseliflavus: first case report 196
Auditory system involvement study in 20 patients with late-onset Pompe disease 195
Variants of the circle of Willis in ischemic stroke patients 194
Bezafibrate-induced myopathy: no evidence for defects in muscle metabolism. 193
Pimozide and pancreatic cancer in diabetic chorea: a case report 193
Sleep and sleep‐modifying factors in chronic migraine patients during the COVID‐19 lockdown 191
A new phenotype of muscle glycogen synthase deficiency (GSD0B) characterized by an adult onset myopathy without cardiomyopathy 191
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 190
A case of vacuolar myopathy during the course of chronic hepatitis C. 189
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) 189
Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias 189
A benign case of congenital myotonic dystrophy 186
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 186
ANT1 is reduced in sporadic inclusion body myositis. 185
Isolated Insular Stroke: Clinical Presentation 183
A genetic modifier of symptom onset in Pompe disease 183
Low-carbohydrate ketogenic diet in Mc Ardle's disease: a single-blinded randomized controlled trial 182
A study of auditory system in 20 patients with late onset Pompe disease 182
A MRI evaluation of respiratory function in patients with the late onset form of Pompe disease 182
Analysis of lipid profile in lipid storage myopathy 182
Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita 181
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 179
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 178
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 178
211th ENMC International Workshop:: Development of diagnostic criteria and management strategies for McArdle Disease and related rare glycogenolytic disorders to improve standards of care. 17–19 April 2015, Naarden, The Netherlands 178
Enterococcal meningitis caused by Enterococcus casseliflavus. First case report. 176
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 176
Management of Teenage Stroke in the Acute Setting: Two Case Reports 175
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 174
Autoimmune juvenile limb-girdle myasthenia 174
Apoptosis and apoptosis-related proteins in thyroid myopathies 173
A novel Cx32 mutation with unusual phenotype. 173
Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy 173
Acute ischemic stroke due to endocarditis from Brucella infection 173
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 172
AUDITORY SYSTEM INVOLVEMENT IN LATE ONSET POMPE DISEASE: A STUDY OF 20 ITALIAN PATIENTS 172
Clinical and electrophysiological characterization in a cohort of italian patients with different forms of hereditary spastic paraplegia 171
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07) 170
Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated? 168
Amyloid myopathy presenting with rhabdomyolysis: Evidence of complement activation 167
Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance 167
Flecainide-responsive myotonia permanens with SNEL onset: A new case and literature review 166
A novel mithocondrial tRNAHys point mutation in a patient with PSP-like phenotype. 165
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 165
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 165
Clinical and muscle magnetic resonance imaging study of an Italian family with autosomal dominant inclusion body myopathy not linked to known genetic loci 164
A NOVEL MUTATION IN KIF5A GENE CAUSING HEREDITARY SPASTIC PARAPLEGIA WITH AXONAL NEUROPATHY; 164
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 164
Acute parkinsonism as first manifestation of systemic lupus erythematosus unmasked by CMV infection. 164
Dolori muscolari, deficit di forza e/o disturbi sensitivi 164
Chronic migraine in the first COVID‐19 lockdown: the impact of sleep, remote working, and other life/psychological changes 164
Deficit multiplo di Acyl-CoA deidrogenasi responsivo alla riboflavina (MADD-RR): studio clinico, biochimico, genetico e spettroscopico 163
Auditory system involvement study in 20 patients with lateonset pompe disease 163
Homozygosity for the common GAA gene splice site mutation c.-32-13T>G in Pompe disease is associated with the classical adult phenotypical spectrum 163
Primary CNS infiltrative parenchymal histiocytosis 163
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 161
MuSK-Associated Myasthenia Gravis: Clinical Features and Management 160
Repeated reperfusion treatment in recurrent ischemic stroke: A retrospective single-center case series 160
208th ENMC International Workshop: Formation of a European Network to develop a European data sharing model and treatment guidelines for Pompe disease. 159
Severe congenital myasthenic syndrome associated with novel biallelic mutation of the CHRND gene 159
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 158
Minor stroke with bilateral acute infarctions and combined vascular anomalies: A complex case report 158
Ischemic stroke due to hypoperfusion in a patient with a previously unrecognized Danon disease 157
Recurrent intracranial hemorrhage and cerebral venous sinus thrombosis: an atypical case of Neuro-Behçet’s Syndrome 157
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 156
Fatal R631C mutation is also present in the adult form of CPTII deficiency 156
Facioscapulohumeral Muscular Dystrophy and Poliomyelitis followed by Multiple Sclerosis: A “triple trouble” case report and review of the literature on the association of MS and muscle disorders 156
Juvenile limb-girdle myasthenia gravis 155
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 155
About the physiopathological mechanism of statin myopathy: evidence of a diffuse reduction of CoQ10 levels in skeletal muscle. 155
Severe rhabdomyolysis in a patient with “Heat Stroke” 155
An unusual association of dominant optic atrophy with OPA1 mutations and parkinsonian syndrome. 154
Miopatie metaboliche 154
Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). 153
Totale 19.241
Categoria #
all - tutte 200.671
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 200.671


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.234 0 0 0 133 139 40 241 118 58 203 319 983
2022/20236.287 551 522 300 410 416 587 88 347 2.811 23 168 64
2023/20241.760 137 246 137 138 123 358 22 173 14 152 48 212
2024/20258.656 140 74 135 528 396 303 229 1.596 2.181 477 959 1.638
2025/202625.386 1.138 1.790 2.238 1.843 1.965 5.185 3.045 2.956 3.053 1.140 508 525
2026/20275.461 993 1.538 1.252 1.678 0 0 0 0 0 0 0 0
Totale 56.548